DMIIU
NASDAQ
$10.14
Drugs Made In America Acquisition II Corp - Units (1 Ord Shs & 1 Rts) (DMIIU)
Drugs Made In America Acquisition II Corp. (DMIIU) is a special purpose acquisition company (SPAC) focused on merging with transformative companies in the pharmaceutical and biotechnology sectors, with a specific emphasis on enhancing domestic drug manufacturing. By investing in businesses that showcase innovative technologies and solid operational strategies, DMIIU aims to tackle significant challenges within the healthcare landscape. The company's mission is to generate substantial shareholder value while playing a vital role in the advancement of the American healthcare system, driving efficiency and effectiveness in domestic drug production. Through its strategic investment paradigm, DMIIU is positioned to lead the charge in revolutionizing the pharmaceutical manufacturing space.
This company is also listed under the following tickers: DMIIR, DMII.
Market Cap
$139M
P/E Ratio
34.88
Free Cash Flow Yield
-0.70%
Beta (5Y)
0.02
Price Chart
Valuation
Market Cap$139M
P/E34.88
Profitability
EBITDA$8.58M
EPS$0.29
Financial Health
Debt-to-Equity-2.5%
Free Cash Flow Yield-0.70%
Growth & Risk
Beta (5Y)0.02
Sharpe Ratio-0.50